Innova Captab Ltd vs Lincoln Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Innova Captab Ltd is ₹ 751.1 as of 30 Apr 15:30 . The P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 39.2 on March 2025 . This represents a CAGR of 20.05% over 2 yearsThe P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 7.2 on March 2021 to 13.4 on March 2025 . This represents a CAGR of 13.23% over 5 years The Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 5021 crore on March 2025 . This represents a CAGR of 39.93% over 2 yearsThe Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 449.4 crore on March 2021 to ₹ 1104 crore on March 2025 . This represents a CAGR of 19.71% over 5 years The revenue of Innova Captab Ltd for the Dec '25 is ₹ 451.95 crore as compare to the Sep '25 revenue of ₹ 384.57 crore. This represent the growth of 17.52% The revenue of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 181.47 crore as compare to the Sep '25 revenue of ₹ 170.6 crore. This represent the growth of 6.37% The ebitda of Innova Captab Ltd for the Dec '25 is ₹ 71.05 crore as compare to the Sep '25 ebitda of ₹ 56.05 crore. This represent the growth of 26.76% The ebitda of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 38.74 crore as compare to the Sep '25 ebitda of ₹ 32.66 crore. This represent the growth of 18.62% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 42.15 crore over 7 quarters. This represents a CAGR of 22.67% The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 23.67 crore to ₹ 28.6 crore over 7 quarters. This represents a CAGR of 11.42% The Dividend Payout of Innova Captab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 4.83 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of -1.94% over 5 years .

About Innova Captab Ltd

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
All the assets and business of the erstwhile partnership were transferred to the Company.
The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

FAQs for the comparison of Innova Captab Ltd and Lincoln Pharmaceuticals Ltd

Which company has a larger market capitalization, Innova Captab Ltd or Lincoln Pharmaceuticals Ltd?

Market cap of Innova Captab Ltd is 4,298 Cr while Market cap of Lincoln Pharmaceuticals Ltd is 1,292 Cr

What are the key factors driving the stock performance of Innova Captab Ltd and Lincoln Pharmaceuticals Ltd?

The stock performance of Innova Captab Ltd and Lincoln Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Innova Captab Ltd and Lincoln Pharmaceuticals Ltd?

As of May 4, 2026, the Innova Captab Ltd stock price is INR ₹751.1. On the other hand, Lincoln Pharmaceuticals Ltd stock price is INR ₹645.4.

How do dividend payouts of Innova Captab Ltd and Lincoln Pharmaceuticals Ltd compare?

To compare the dividend payouts of Innova Captab Ltd and Lincoln Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.